RESMED Aktie

 

These shares are starting the week in the red. But why? The post Why DroneShield, Lendlease, PlaySide, and ResMed shares are tumbling today appeared first on The Motley Fool Australia....

CSL is at a 10-year low. Cochlear has fallen 62%. ResMed is down on fears that proved wrong. Are any of the three worth buying now? The post These 3 ASX healthcare stocks have been crushed in 2026. They could be set for a comeback appeared first on The Motley Fool Australia....

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

ResMed shares are down in 2026 on GLP-1 fears. But new data shows obesity drugs are actually driving more patients to CPAP therapy. Here is why investors should take notice. The post The global obesity drug boom could be bigger than investors realise for this ASX stock appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

Investors need to pay close attention to RMD stock based on the movements in the options market lately....

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care....

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 46th Annual William Blair Growth Stock Conference in Chicago, IL on Tuesday, June 2, 2026. Resmed's webcast presentation will begin at approximately 4:40 p.m. (Central Time)....

Oura Members can take action on changes in sleep or breathing patterns through educational resources from Resmed and pathways for accessing care Oura Members can take action on changes in sleep or breathing patterns through educational resources from Resmed and pathways for accessing care...

Are analysts bullish on these popular stocks? Let's see what they are saying this week. The post Buy, hold, sell: ResMed, Sigma, and TechnologyOne shares appeared first on The Motley Fool Australia....

Resmed shares have had a tough time of late. But investors looking to compound returns over the long-term may want to consider this opportunity. The post Why are Resmed shares lagging if the business keeps compounding? appeared first on The Motley Fool Australia....

This company is still growing, profitable, and exposed to a large sleep health market, but the share price has fallen sharply. The post Should you buy ResMed shares at their 52-week low? appeared first on The Motley Fool Australia....

Farrell, Michael J. - Vorstand - Tag der Transaktion: 2026-05-07...

Is Morgans bullish or bearish on these popular shares? Let's find out. The post Buy, hold, sell: Coles, Liontown, and ResMed shares appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Resmed beats Q3 earnings and revenue estimates with strong margin gains, yet shares slip post earnings despite growth across key segments....

Find insight on Eli Lilly and ResMed in the latest Market Talks covering Health Care....

These shares are ending the week in the red. But why? The post Why EQ Resources, Inghams, ResMed, and Skycity shares are tumbling today appeared first on The Motley Fool Australia....

The sleep disorder treatment company has released its third-quarter update this morning. The post What's going on with ResMed shares today? appeared first on The Motley Fool Australia....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...